Recent Finacing
Recent Raise
Entact Bio develops a preclinical Encompass platform that designs enhancement-targeting chimeric (ENTAC) molecules to recruit deubiquitinases, integrating biological, chemical, and computational tools to restore or boost protein function.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
